Urban Juve Launches New Line into Booming Hand Sanitizer Markets in U.S. and Canada

The novel coronavirus better known as COVID-19 has health authorities around the world issuing guidance for people to remain vigilant in proper hand hygiene. It may have taken COVID-19 to scare people into proper hand maintenance, but the fact is that the World Health Organization has been preaching this practice for decades to avoid disease contamination.

WHO & CDC: Use Hand Sanitizer!

If you think WHO is talking about lathering up religiously, you’re wrong. WHO actually recommends to: “Clean your hands by rubbing them with an alcohol-based formulation, as the preferred mean for routine hygienic hand antisepsis if hands are not visibly soiled. It is faster, more effective, and better tolerated by your hands than washing with soap and water.”

Both WHO and the U.S. Centers for Disease Control and Prevention recommend using hand sanitizer with at least 60% alcohol to kill viruses, including SARS-CoV-2, the coronavirus responsible for COVID-19.

Here Comes BOSS

Now that that world seems to “get it,” hand sanitizer sales are booming, making it opportune timing for The Yield Growth Corp. (CSE: BOSS)(OTCQB: BOSQF) and its Urban Juve subsidiary to bring its new Urban Juve natural hand sanitizers to the masses.

“It’s unfortunate that it took something like COVID-19 to open people’s eyes to the importance of having hand sanitizer at all times,” commented Penny White, CEO of Yield Growth in a phone conversation with Baystreet.ca. “From a business perspective, though, we suspect that we’ll have a successful launch as we ride the momentum of the Urban Juve brand into an explosive market.”

“Explosive” is putting it lightly. A recent research report by Arizton lends more color, forecasting more than 600% year-over-year growth to see the hand sanitizer market reach $11 billion in 2020. Simply, hand sanitizer has become a household (and vehicle, pocket and purse) staple because of the coronavirus pandemic.

Approvals in Tow, Marketing on Tap

Urban Juve moved quickly to get its products completed and through approval processes of health authorities in North America. In a matter of weeks, the company received two approvals from Health Canada for hand sanitizer products (a gel and a liquid spray) via fast track applications meant to get new goods to market to combat the spread of COVID-19.

Exceeding WHO and CDC guidelines for virus destruction, the Urban Juve hand sanitizers contain 65% ethyl alcohol. The unique formulations mean that the dehydrating effects of alcohol are offset by nourishing and hydrating essential oils.

Urban Juve started taking pre-orders for the hand sanitizer products in Canada this week for delivery in May.

Now the company can add acceptance by the U.S. Food and Drug Administration to its accomplishments. Yield Growth said Wednesday that the FDA accepted the listing for its Urban Juve hand sanitizer gel to allow it to be sold in the U.S.

With the FDA listing, Urban Juve will begin taking orders for the new product in May for delivery to U.S. retailers and consumers in July.

Doing the Right Thing

Yield Growth is taking a philanthropic approach to help those on the front-line fighting COVID-19, many of which are working tirelessly without proper personal protection equipment, including hand sanitizer. Yield Growth has adopted a policy to donate hand sanitizer products to COVID-19 front line workers and has allocated 1,000 units for initial donations. Through Urban Juve’s Instagram, Twitter, and Facebook accounts followers will be asked to nominate communities most in need of supplies.

Given the desperate need for hand sanitizers amongst first responders, hospital workers, etc., it’s a breath of fresh air to see a little company doing some good while so many opportunists are out there trying to price gouge and others hoard as they look to profit from others suffering. Kudos to Yield Growth for being part of the solution.

Legal Disclaimer/Disclosure: While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Furthermore, it is certainly possible for errors or omissions to take place regarding the profiled company, in communications, writing and/or editing. Nothing in this publication should be considered as personalized financial advice. We are not licensed under any securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this article is not provided to any individual with a view toward their individual circumstances. Baystreet.ca has been paid a fee of twenty thousand dollars for The Yield Growth Corp. advertising from the company. There may be 3rd parties who may have shares of The Yield Growth Corp. and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article as the basis for any investment decision. The owner/operator of Baystreet.ca has purchased shares of The Yield Growth Corp. through a private placement and does not intend on selling any shares within 72 hours of this updated publication date after such point we reserve the right to buy and sell shares in the open market, no further notice will be given. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing Baystreet.ca, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.